Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity

British Journal of Cancer

Volumn 91, Issue 6, 2004, Pages 1213-1219

  Jones, D J L ^a   Lamb, J H ^a   Verschoyle, R D ^a   Howells, L M ^a   Butterworth, M ^a   Lim, C K ^b   Ferry, D ^c   Farmer, P B ^a   Gescher, A J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NEW CROSS HOSPITAL   (United Kingdom)

Author keywords

Cancer chemoprevention; Cyclo oxygenase; Metabolism; Quercetin

Indexed keywords

CYCLOOXYGENASE 2; GLUTATHIONE; ISORHAMNETIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; QUERCETIN; QUERCETIN 3 O SULFATE; QUERCETIN 7 O SULFATE; QUERCETIN DERIVATIVE; RUTOSIDE; TAMARIXETIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BILE LEVEL; BLOOD LEVEL; CANCER CELL CULTURE; CANCER PREVENTION; CHEMICAL STRUCTURE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG BIOAVAILABILITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; MASS SPECTROMETRY; METABOLITE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; URINE LEVEL;

ANIMALS; ANTICARCINOGENIC AGENTS; BIOLOGICAL TRANSPORT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINOPROSTONE; HUMANS; MALE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; QUERCETIN; RATS; RATS, INBRED F344;

EID: 5044232069     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602091     Document Type: Article

References (48)

1. Ader P, Wessmann A, Wolffram S (2000) Unavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 28: 1056-1067
2. Awad HM, Boersma MG, Boeren S, van Bladeren PJ, Vervoort J, Rietjens IMCM (2001) Structure - activity study on the quinone/quinone methide chemistry of flavonoids. Chem Res Toxicol 14: 398-408
3. Awad HM, Boersma MG, Vervoort J, Rietjens IMCM (2000) Peroxidase-catalyzed formation of quercetin quinone methide - glutathione adducts. Arch Biochem Biophys 378: 224-233
4. Boersma MG, Vervoort J, Szymusiak H, Lemanska K, Tyrakowska B, Cenas N, Segura-Aguilar J, Rietjens IMCM (2000) Regioselectivity and reversibility of the glutathione conjugation of quercetin quinone methide. Chem Res Toxicol 13: 185-191
5. Booth AN, Murray CW, Jones FT, DeEds F (1956) Metabolic fate of rutin and quercetin in the animal body. J Biol Chem 233: 251-257
6. Butterworth M, Lau SS, Monks TJ (1997) Formation of catechol estrogen glutathione conjugates and gamma-glutamyl transpeptidase-dependent nephrotoxicity of 17 beta-estradiol in the golden Syrian hamster. Carcinogenesis 18: 561-567
7. CanivencLavier MC, Vernevaut MF, Totis M, Siess MH, Magdalou J, Suschetet M (1996) Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver. Toxicology 114: 19-27
8. Carvalho M, Milhazes N, Remiao F, Borges F, Fernandes E, Amado F, Monks TJ, Carvalho F, Bastos ML (2004) Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Arch Toxicol 78: 16-24
9. Da Silva EL, Piskula MK, Yamamoto N, Moon JH, Terao J (1998) Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Let 430: 405-408
10. Day AJ, Bao, YP, Morgan MRA, Williamson G (2000) Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 29: 1234-1243
11. Day AJ, Mellon F, Barren D, Sarrazin G, Morgan MRA, Williamson G (2001) Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 35: 941-952
12. Douglass CD, Hogan R (1958) Formation of protocatechuic acid from quercetin by rat kidney in vitro. J Biol Chem 230: 625-629
13. Dunnick JK, Hailey JR (1992) Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fund Appl Toxicol 19: 423-431
14. Duckworth HW, Coleman JE (1970) Physiochemical and kinetic properties of mushroom tyrosinase. J Biol Chem 245: 1613-1625
15. Ferry DR, Smith A, Malkhandi J, Pyfe DW, deTakats PG, Anderson D, Baker J, Kerr DJ (1996) Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 2: 659-668
16. Formica JV, Regelson W (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33: 1061-1080
17. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE (1966) Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 50: 219-244
18. Galati G, Moridani MY, Chan TS, O'Brien PJ (2001) Peroxidative metabolism of apigenin and naringenin vs luteplin and quercetin: glutathione oxidation and conjugation. Free Radic Biol Med 30: 370-382
19. Gescher AJ, Steward WP (2003) Commentary: relationship between mechanisms, bioavailibility and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev 12: 953-957
20. Gugler R, Leschik M, Dengler HJ (1975) Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 9: 229-234
21. Hertog MGL, Hollman PCH, Katan MB (1992) Content of potentially anticarcinogenic flavonoids of 28 vegetables and 19 fruits commonly consumed in the Netherlands. J Agr Food Chem 40: 2379 -2383
22. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease - the Zutphen elderly study. Lancet 342: 1007-1011
23. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D (1994) Dietary flavonoids and cancer risk in the Zutphen elderly study. Nutr Cancer 22: 175-184
24. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic BS, Toshima H, Feskens EJM, Hollman PCH, Katan MB (1995) Flavonoid intake and long-term risk of coronary-heart-disease and cancer in the seven countries study. Arch Intern Med 155: 381-386
25. Hertog MGL, Hollman PCH (1996) Potential health-effects of the dietary flavonol quercetin. Eur J Clin Nutr 50: 63-71
26. Hollman PCH, Katan MB (1997) Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother 51: 305-310
27. Iverson SL, Shen L, Anlar N, Bolton JL (1996) Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes. Chem Res Toxicol 9: 492-499
28. Jones DJL, Lim CK, Ferry DR, Gescher A (1998) Determination of quercetin in human plasma by HPLC with spectrophotometric or electrochemical detection. Biomed Chromatogr 12: 232-235
29. Keli SO, Hertog MGL, Feskens EJM, Kromhout D (1996) Dietary flavonoids, antioxidant vitamins, and incidence of stroke - the Zutphen study. Arch Intern Med 156: 637-642
30. Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN (2000) Intake of flavonoids and lung cancer. J Natl Cancer Inst 92: 154-160
31. MacGregor JT, Jurd L (1978) Mutagenicity of plant flavonoids: Structural requirements for mutagenic activity in Salmonella typhimurium. Mutat Res 54: 297-309
32. Manach C, Morand C, Demigne C, Texier O, Regerat F, Remesy C (1997) Bioavailability of rutin and quercetin in rats. FEBS Lett 409: 12-16
33. Manach C, Morand C, Crespy V, Demigne C, Texier O, Regerat F, Remesy C (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426: 331-336
34. Marnett LJ, DuBois RN (2002) COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol 42: 55-80
35. Merfort I, Heilmann J, Weiss M, Pietta P, Gardana C (1996) Radical scavenger activity of 3 flavonoid metabolites studied by inhibition of chemiluminescence in human PMNs. Planta Med 62: 289-292
36. Monks TJ, Lau SS, Highet RJ, Gillette JR (1985) Glutathione conjugates of 2-bromohydroquinone are nephrotoxic. Drug Metab Dispos 13: 553-559
37. Mutoh H, Takahashi M, Fukuda K, Komatsu H, Enya T, Matsushima-Hibiya Y, Sugimura T, Wakabayashi K (2000) Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure - activity relationship. Jpn J Cancer Res 91: 686-691
38. Nijhoff W, Groen AGM, Peters WHM (1993) Induction of rat hepatic and intestinal glutathione S-transferases and glutathione by dietary naturally-occurring anticarcinogens. Int J Oncol 3: 1131-1139
39. Nijveldt RJ, van Nood E, van Hoorn DEC, Boelens PG, van Norren K, van Leeuwen PAM (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74: 418-425
40. Peters MMCG, Jones TW, Monks TJ, Lau SS (1997) Cytotoxicity and cell-proliferation induced by the nephrocarcinogen hydroquinone and its nephrotoxic metabolite 2,3,5-(tris-glutathion-S-yl)hydroquinone. Carcinogenesis 18: 2393-2401
41. Petrakis PL, Kallianos AG, Wender SH, Shetlar MR (1959) Metabolic studies of quercetin labeled with C14. Arch Biochem Biophys 85: 264-271
42. Piskula MK, Terao J (1998) Quercetin's solubility affects its accumulation in rat plasma after oral administration. J Agric Food Chem 46: 4313-4317
43. Raso GM, MeIi R, Di Carlo G, Pacilio M, Di Carlo R (2001) Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 68: 921-931
44. Sahu SC, Gray GC (1996) Prooxidant activity of flavonoids - effects on glutathione and glutathione-S-transferase in isolated rat-liver nuclei. Cancer Lett 104: 193-196
45. Shali NA, Curtis CG, Powell GM, Roy AB (1991) Sulphation of the flavonoids quercetin and catechin by rat-liver. Xenobiotica 21: 881 -893
46. Sharma RA, Gescher AJ, Plastaras JP, Leuratti C, Singh R, Gallacher-Horley B, Offord E, Marnett LJ, Steward WP, Plummer SM (2001) Cyclooxygenase-2 activity, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells. Carcinogenesis 22: 1557-1560
47. Ueno I, Nakano N, Hirono I (1983) Metabolic-fate of [C-14] quercetin in the ACl rat. Jpn J Exp Med 53: 41-50
48. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables, J Stephens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). Br J Cancer 77: 1-10